Xtant Medical Holdings Inc (XTNT)
0.527
+0.06
(+12.58%)
USD |
NYAM |
Jan 03, 16:00
0.499
-0.03
(-5.31%)
After-Hours: 20:00
Xtant Medical Holdings SG&A Expense (Quarterly): 19.38M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Plus Therapeutics Inc | 2.397M |
| Perspective Therapeutics Inc | 6.975M |
| Retractable Technologies Inc | 4.946M |
| InfuSystems Holdings Inc | 15.53M |
| Catheter Precision Inc | 2.882M |